Assist. Prof. Dr. sumaira Javaid | Strutural biology | Best Researcher Award

Assist. Prof. Dr. sumaira Javaid | Strutural biology | Best Researcher Award

Assist. Prof. Dr sumaira Javaid, Dr. Panjwani Center for Molecular Medicine and Drug Research, Pakistan

Sumaira Javaid is an esteemed scientist specializing in bio-organic chemistry, molecular, and structural biology. With over eight years of post-Ph.D. experience, she has built an impactful career in academia and research. Dr. Javaid completed her Ph.D. at the H.E.J. Research Institute of Chemistry, University of Karachi, where she focused on chemical compounds with potential anti-angiogenic, antioxidant, and myelin repair properties. She furthered her studies as a post-doctoral fellow at the Institut de Pharmacologie et de Biologie Structurale (IPBS) in France. Dr. Javaid has published 17 research papers, with a combined impact factor of 77 and an h-index of 10. Her contributions to the scientific community have garnered 358 citations. As an assistant professor at the University of Karachi, she continues to guide students and conduct groundbreaking research. Her work is recognized through prestigious awards, including post-doctoral fellowships and scholarships.

Professional Profile

orcid

google scholar

Summary of Suitability for the Research for Best Researcher Award 

Dr. Sumaira Javaid is a strong candidate for the Research for Best Researcher Award. Her international exposure, innovative research, significant scholarly contributions, and mentorship abilities highlight her suitability for this award. Her work addresses critical issues in structural biology and enzyme inhibition, contributing to advancements in health and disease management, making her a well-rounded and deserving candidate.

🎓  Education 

Sumaira Javaid’s academic journey is marked by excellence in biochemistry and chemistry. She earned her Ph.D. in Chemistry from the H.E.J. Research Institute of Chemistry at the University of Karachi in 2016. Her dissertation titled “Screening of Chemical Compounds (Secondary Metabolites and Heterocyclic Synthetic Compounds) for Their Anti-Angiogenic, Anti-Oxidant, and CNS Myelin Repair Activities” demonstrated her expertise in bio-organic chemistry. Sumaira also holds an M.Sc. in Biochemistry from the University of Karachi, where she secured second position in her department. Her master’s thesis explored the behavioral effects of starvation and restricted feeding in rats. Additionally, she completed her B.Sc. (Hons) with majors in Biochemistry, Chemistry, and Microbiology from the same institution. Sumaira’s passion for research led her to pursue a post-doctoral fellowship at the Institut de Pharmacologie et de Biologie Structurale in Toulouse, France, focusing on advanced biopharmacology and structural biology from 2017 to 2018.

💼  Experience 

Sumaira Javaid brings over a decade of diverse experience in academia and research. Since September 2019, she has been an Assistant Professor at the Dr. Punjwani Center for Molecular Medicine and Drug Research, University of Karachi. She previously served as a Research Officer at the same institution and completed a one-year post-doctoral fellowship at the Institut de Pharmacologie et de Biologie Structurale (IPBS), France. Her international exposure includes a visiting scientist role at Université Paul Sabatier in Toulouse and research fellowships at renowned institutes like the National Institute for Health and Medical Research, Paris. At the H.E.J. Research Institute, University of Karachi, she was a Senior Research Fellow and later a Junior Research Fellow, contributing to advanced studies in enzyme inhibition, biochemistry, and molecular research. Sumaira has also supervised several M.Phil. and Ph.D. students, guiding their research in cancer treatment, neurobiology, and microbial enzyme inhibition.

 🏅 Awards and Honors 

Sumaira Javaid has been recognized for her outstanding contributions to research with several prestigious awards. She was awarded a Post-Doctoral Fellowship in France (2017-2018) under the Faculty Development Program, providing her the opportunity to further her studies at the Institut de Pharmacologie et de Biologie Structurale (IPBS). In 2012, she received the H.E.C. & French Embassy Split PhD and Post-Doctoral Fellowship Program award, which supported her advanced research in France and Pakistan. Throughout her academic career, Sumaira has also been acknowledged for her academic merit, having received a Merit-cum-Need Scholarship in 2005 during her undergraduate studies. Her work has been consistently recognized for its scientific impact, and she continues to be a leading figure in molecular and structural biology research. These accolades are a testament to her dedication, excellence, and influence in the field of bio-organic chemistry.

🌍  Research Focus 

Sumaira Javaid’s research focuses on bio-organic chemistry and molecular biology, with particular expertise in enzyme inhibition, biopharmaceuticals, and structural biology. Her Ph.D. research centered on exploring the anti-angiogenic, antioxidant, and myelin repair properties of secondary metabolites and synthetic compounds. She has a strong background in biomolecular NMR spectroscopy, protein purification, and enzyme inhibition assays. Sumaira’s research seeks to understand complex biochemical pathways, especially in the context of cancer treatment, neurodegenerative diseases, and infectious diseases. Her recent work has included biophysical methods to identify enzyme inhibitors that have potential therapeutic applications, particularly in treating neurological diseases and microbial infections. She has also contributed significantly to cell culturing techniques, immunohistochemistry, and immunocytochemistry. Sumaira’s collaborative projects with international institutions have expanded her research into structural biology and pharmacology, enhancing her contributions to drug discovery and molecular medicine.

 📖 Publication Top Notes

  • Title: Unexpected central role of the androgen receptor in the spontaneous regeneration of myelin

    Cited by: 122

  • Title: Zwitterionic pyrimidinium adducts as antioxidants with therapeutic potential as nitric oxide scavenger

    Cited by: 60

  • Title: Synthesis, molecular docking and xanthine oxidase inhibitory activity of 5-aryl-1H-tetrazoles

    Cited by: 35

  • Title: Synthesis and urease inhibitory activities of benzophenone semicarbazones/thiosemicarbazones

    Cited by: 27

  • Title: 2-Arylquinazolin-4(3H)-ones: A novel class of thymidine phosphorylase inhibitors

    Cited by: 16

 

Arnulf Stenzl | Health Professions | Academic Excellence Award

Prof Dr Arnulf Stenzl | Health Professions | Academic Excellence Award

Prof Dr Arnulf Stenzl, Universität Tübingen, Tübingen Deutschland ,Germany

Prof. Dr. Arnulf Stenzl is an Austrian-born urologist and global leader in urological oncology. He received his medical degree from Karl-Franzens University in Graz, Austria, in 1980 and subsequently trained in surgery and urology across Austria, Switzerland, and the United States. Since 2002, he has headed the Department of Urology at Eberhard-Karls University in Tübingen, Germany, where he oversees critical research on urological cancers. Prof. Stenzl’s contributions extend internationally, with membership in numerous editorial boards and global collaborations. He has played a pivotal role in shaping European urological policies as Secretary General of the European Association of Urology. His work has led to several groundbreaking patents in the field, furthering innovations in patient care.

Professional Profile

Education 

Prof. Dr. Arnulf Stenzl embarked on his academic journey in 1973 when he enrolled at Karl-Franzens University in Graz, Austria, where he earned his Doctor medicinae universalis (M.D.) in February 1980. His initial training spanned internal medicine, nephrology, and pathology at Landeskrankenhaus Klagenfurt and Karl-Franzens University. From 1984 to 1987, he undertook specialized training in urology, first at Karl-Franzens University, then further expanding his knowledge as a fellow in general urology and urologic oncology at the University of California, Los Angeles (UCLA). His education, which encompassed diverse fields such as trauma, vascular, and plastic surgery, provided him with a holistic understanding of medicine and surgery. His dedication to learning has been reflected in his ongoing research and innovative contributions to urology.

Experience 

Prof. Dr. Arnulf Stenzl has had a distinguished career spanning over three decades. After serving as an assistant professor at the University of Bern in Switzerland, he moved to the University of Innsbruck, Austria, where he eventually became vice-chairman of the Department of Urology. Since 2002, he has led the Department of Urology at Eberhard-Karls University Tübingen, Germany, overseeing the clinical, academic, and research arms of the institution. Prof. Stenzl has driven numerous groundbreaking research projects, collaborating with both academic and industrial partners. As Secretary General of the European Association of Urology, he has led European urological research and development initiatives. His expertise extends to cancer research, with numerous contributions to advancing treatment modalities for bladder and prostate cancer.

Awards and Honors 

Prof. Dr. Arnulf Stenzl’s career is marked by numerous prestigious awards and honors. He is an honorary member of several international urological societies, including the Bristol Urological Institute and the Canadian Urological Association. His service as President of the German Urological Association (2020-2021) highlights his leadership within the field. Additionally, his involvement as Chairman of the Scientific Congress Office for the European Association of Urology and his role on the Board of Directors of the European CanCer Organisation demonstrate his commitment to global urological advancement. Prof. Stenzl’s contributions to scientific literature have earned him multiple editorial board memberships. His innovative spirit is further evidenced by several patents, including implantable devices to treat urinary incontinence and risk prediction models for renal cell carcinoma.

Research Focus 

Prof. Dr. Arnulf Stenzl’s research is at the forefront of urological oncology, focusing on advanced treatment modalities for bladder and prostate cancers. His work delves into personalized cancer therapies, optimizing clinical outcomes through precision medicine approaches. A significant aspect of his research revolves around biomarker discovery and risk stratification, which aim to enhance early diagnosis and targeted treatment. He has contributed to pioneering studies in immunotherapy, including innovative techniques for bladder cancer surgery and the integration of novel hormonal therapies in prostate cancer treatment. Prof. Stenzl is also involved in collaborative research projects with industry, furthering the development of next-generation urological treatments. His innovative contributions have resulted in several patents, solidifying his standing as a leader in urological research and technology.


Publications top notes

  • Treatment Intensification With Novel Hormonal Therapy in Prostate Cancer 📚🧪
  • Sacituzumab Govitecan Efficacy in Urothelial Cancer 🧬🔬
  • Co-occurring BRCA2/SPOP Mutations and PARP Inhibitor Sensitivity 🧬⚕️
  • Epacadostat Plus Pembrolizumab for Urothelial Carcinoma 💉🧪
  • Impact of Teratoma on Survival in Germ Cell Cancer 🧫🩺
  • Sacituzumab Govitecan & Pembrolizumab in Urothelial Cancer 💊🧪
  • TROPHY-U-01 Study on Sacituzumab Govitecan in Metastatic Urothelial Cancer 🧬🔬
  • Efficacy of Darolutamide in Black Patients With Prostate Cancer ⚕️🩺
  • Alpha Emitter for Metastatic Castration-Resistant Prostate Cancer 🧬💉